MAHBOOB ALAM to Cardiovascular Diseases
This is a "connection" page, showing publications MAHBOOB ALAM has written about Cardiovascular Diseases.
Connection Strength
0.981
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
Score: 0.093
-
Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Jul 23; 31(9):1123-1131.
Score: 0.090
-
Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease. Am J Med. 2023 12; 136(12):1147-1159.
Score: 0.084
-
Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis. Am J Cardiol. 2023 08 15; 201:92-100.
Score: 0.084
-
A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
Score: 0.074
-
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug; 21(4):559-570.
Score: 0.071
-
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 2022 02; 36(1):93-102.
Score: 0.070
-
Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol. 2020 02 01; 300:106-112.
Score: 0.064
-
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.061
-
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
Score: 0.058
-
Premature Coronary Heart Disease in South Asians: Burden and Determinants. Curr Atheroscler Rep. 2018 01 27; 20(1):6.
Score: 0.057
-
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
Score: 0.047
-
Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol. 2014 Dec 09; 64(22):2434-5.
Score: 0.046
-
Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7.
Score: 0.044
-
Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry. Expert Rev Cardiovasc Ther. 2012 Mar; 10(3):283-91.
Score: 0.038